{"cik":2029039,"taxonomy":"us-gaap","tag":"OperatingIncomeLoss","label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","entityName":"Nasus Pharma Ltd","units":{"USD":[{"start":"2023-01-01","end":"2023-12-31","val":-1147000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2023"},{"start":"2024-01-01","end":"2024-06-30","val":-483000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"start":"2024-01-01","end":"2024-12-31","val":-1078000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2024"},{"start":"2025-01-01","end":"2025-06-30","val":-817000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"start":"2025-01-01","end":"2025-12-31","val":-4904000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025"}]}}